Salinomycin inhibits Wnt signaling and selectively induces apoptosis in chronic lymphocytic leukemia cells

Desheng Lu, Michael Y. Choi, Jian Yu, +3

Proceedings of the National Academy of Sciences

Venetoclax for chronic lymphocytic leukaemia progressing after ibrutinib: an interim analysis of a multicentre, open-label, phase 2 trial

Jeffrey A. Jones, Anthony R. Mato, William G. Wierda, +15

The Lancet Oncology

Hematological MalignancyInterim AnalysisLymphoid NeoplasiaMedicineImmunology +7

Venetoclax plus rituximab in relapsed or refractory chronic lymphocytic leukaemia: a phase 1b study

John F. Seymour, Shuo Ma, Danielle M. Brander, +20

The Lancet Oncology

Phase 1BLymphoid NeoplasiaHematological MalignancyMedicineImmunology +8

Thrombospondins 1 and 2 are Necessary for Synaptic Plasticity and Functional Recovery after Stroke

Jason Liauw, Stanley Hoang, Michael Y. Choi, +9

Journal of Cerebral Blood Flow & Metabolism

Phase I Trial: Cirmtuzumab Inhibits ROR1 Signaling and Stemness Signatures in Patients with Chronic Lymphocytic Leukemia

Michael Y. Choi, George F. Widhopf, Emanuela M. Ghia, +13

Cell stem cell

Hematological MalignancyStemness SignaturesLymphoid NeoplasiaChronic Lymphocytic LeukemiaMedicine +4

Venetoclax for patients with chronic lymphocytic leukemia who progressed during or after idelalisib therapy

Steven Coutré, Michael Y. Choi, Richard R. Furman, +12

Blood

AGS67E, an Anti-CD37 Monomethyl Auristatin E Antibody–Drug Conjugate as a Potential Therapeutic for B/T-Cell Malignancies and AML: A New Role for CD37 in AML

Daniel S. Pereira, Claudia Guevara, Liqing Jin, +18

Molecular Cancer Therapeutics

ImmunologyImmunotherapeuticsImmunotherapyCancer BiologyTumor Biology +16

A dynamic expression survey identifies transcription factors relevant in mouse digestive tract development

Michael Y. Choi, Anthony I. Romer, Michael H. Hu, +6

Development

SM16, an Orally Active TGF-β Type I Receptor Inhibitor Prevents Myofibroblast Induction and Vascular Fibrosis in the Rat Carotid Injury Model

Kai Fu, Michael J. Corbley, Lihong Sun, +24

Arteriosclerosis Thrombosis and Vascular Biology

Ulocuplumab (BMS-936564 / MDX1338): a fully human anti-CXCR4 antibody induces cell death in chronic lymphocytic leukemia mediated through a reactive oxygen species-dependent pathway

Manoj Kumar Kashyap, Deepak Kumar, Harrison Jones, +12

Oncotarget